Hostname: page-component-745bb68f8f-s22k5 Total loading time: 0 Render date: 2025-02-02T09:44:28.877Z Has data issue: false hasContentIssue false
  • English
  • Français

Studies of Depressive Symptoms in Schizophrenia

Published online by Cambridge University Press:  29 January 2018

D. A. W. Johnson
D. A. W. Johnson*
Affiliation:
University Hospital of South Manchester, West Didsbury, Manchester M20 8LR
Get access Rights & Permissions [Opens in a new window]

Summary

Depression assessed by clinical examination and Hamilton rating scale was found in half of 37 untreated new acute schizophrenics, and in about a third of chronic schizophrenics who relapsed whether treated with depot injections (89) or not (79). A significant part of depressive illness in schizophrenics is thus not drug-related. However, depression was commoner in those on higher doses of depot neuroleptic (P <.05) or who showed extrapyramidal side effects (P <.001), suggesting that drugs can play a part. Patients maintained in remission on moderate doses of depot drug had the lowest prevalence of depression.

Type
Papers
Information
The British Journal of Psychiatry , Volume 139 , Issue 2 , August 1981 , pp. 89 - 101
Copyright
Copyright © Royal College of Psychiatrists, 1981 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Alarcon, R. de & Carney, M. W. P. (1969) Severe depressive mood changes following slow release intramuscular fluphenazine injection. British Medical Journal, iii, 564–7.Google Scholar
Ayd, F. J. (1975) The depot fluphenazines: A reappraisal after ten years' clinical experience. American Journal of Psychiatry, 132, 491—500.Google Scholar
Bennett, I. F., Cohen, D. & Starer, E. (1954) Isoniazid in the treatment of the chronic schizophrenic patient. Archives of Neurology and Psychiatry, 71, 54—65.CrossRefGoogle ScholarPubMed
Brockington, I. F., Kendell, R. E., Kellett, J. M., Curry, S. H. & Wainwright, (1978) Trials of lithium, chlorpromazine and amitriptyline in schizoaffective patients. British Journal of Psychiatry, 133, 162–8.CrossRefGoogle ScholarPubMed
Bowers, M. B. & Astrachan, B. M. (1967) Depression in acute schizophrenic psychosis. American Journal of Psychiatry, 123, 976–9.CrossRefGoogle ScholarPubMed
Chouinard, G., Annable, L. & Serrano, M. (1975) Amitriptyline-perphenazine interaction in ambulatory schizophrenic patients: A controlled study of drug interaction. Archives of General Psychiatry, 32, 1295—1307.CrossRefGoogle ScholarPubMed
Claude, H. (1930) Schizomanie à Forme Imaginative. L'Encephale, 25, 10.Google Scholar
Claude, H., Borel, S. & Robin, G. (1924) Deménce Précoce, schizomanie et schizophrenic. L'Encephale, 19, 45.Google Scholar
Cohen, S., Leonard, C. V., Farberow, N. L. & Shneidman, E. S. (1964) Tranquillizers and suicide in the schizophrenic patient. Archives of General Psychiatry, 11, 312–21.Google Scholar
Conrad, K. (1958) Die Beginnende Schizophrenic: Versuch einer Gestaltanalyse des Wahns. Thieme: Stuttgart. p 315.Google Scholar
Docherty, J. P., van Kammen, D. P., Siris, S. G. & Marder, S. R. (1978) Stages of onset of schizophrenic psychosis. American Journal of Psychiatry, 135, 420–6.Google Scholar
Donlon, P. T. & Blacker, K. H. (1973) Stages of schizophrenia decompensation and reintegration. Journal of Nervous and Mental Disease, 157, 200–8.CrossRefGoogle ScholarPubMed
Extein, I. & Bowers, M. B. (1975) The pharmacological meaning of successful antipsychotic-antidepressant combinations. Comprehensive Psychiatry, 16, 427–34.Google Scholar
Falloon, I., Watt, D. C. & Shepherd, M. (1978) A comparative controlled trial of pimozide and fluphenazine decanoate in the continuation therapy of schizophrenia. Psychological Medicine, 8, 59—70.CrossRefGoogle ScholarPubMed
Farberow, N. L., Shneidman, E. S. & Calista, L. (1961) Suicide among schizophrenic mental hospital patients. In The Cry for Help (eds. Farberow, and Shneidman, ). New York: McGraw Hill.Google Scholar
Freeman, H. (1967) The therapeutic value of combinations of psychotropic drugs: A review. Psychopharmacological Bulletin, 4, 1—27.Google ScholarPubMed
Goldman, D. (1958) Marsilid for hospital psychiatry. Journal for Clinical and Experimental Psychopathology, Supplement 1, 80–5.Google Scholar
Hanlon, T. E., Nussbaum, K. & Wittig, B. (1964) The comparative effectiveness of amitriptyline, perphenazine and their combination in the treatment of chronic psychotic patients. Journal of New Drugs, 4, 52—60.CrossRefGoogle Scholar
Hanlon, T. E., Ota, K. Y. & Kurland, A. A. (1970) Comparative effects of fluphenazine, fluphenazine-chlordiazepoxide and fluphenazine-imipramine. Diseases of the Nervous System, 31, 171–7.Google ScholarPubMed
Hedberg, D. L., Houck, J. H. & Glueck, B. C. (1971) Tranylcypromine-trifluoperazine combination in the treatment of schizophrenia. American Journal of Psychiatry, 127, 1141–6.Google Scholar
Hirsch, S. R., Gaind, R., Rohde, P. D., Stevens, B. C. & Wing, J. K. (1973) Outpatient maintenance of chronic schizophrenic patients with long-acting fluphenazine: double-blind placebo trial. British Medical Journal, i, 633–7.Google Scholar
Johnson, D. A. W. (1973) The side-effects of fluphenazine decanoate. British Journal of Psychiatry, 123, 519–23.Google Scholar
Johnson, D. A. W. (1978) The prevalence and treatment of drug induced extrapyramidal symptoms. British Journal of Psychiatry, 132, 27—30.Google Scholar
Johnson, D. A. W. (1979) Further observations on the duration of depot neuroleptic maintenance therapy in schizophrenia. British Journal of Psychiatry, 135, 524–30.Google Scholar
Johnson, D. A. W. & Heather, B. B. (1974) The sensitivity of the Beck Depression Inventory to changes in symptomatology. British Journal of Psychiatry, 124, 184–5.Google Scholar
Johnson, D. A. W. & Mellor, V. (1977) The severity of depression in patients treated in general practice. Journal of the Royal College of General Practitioners, 27, 419–22.Google ScholarPubMed
Klein, D. F. & Davis, J. M. (1969) Diagnosis and Drug Treatment of Psychiatric Disorders. Baltimore: Williams and Wilkins. p 165.Google Scholar
Klein, D. F. & Fink, M. (1962) Psychiatric reaction patterns to imipramine. American Journal of Psychiatry, 119, 432–8.CrossRefGoogle ScholarPubMed
Klein, D. F. (1965) Behavioural effects of imipramine and phenothiazines. Biological Psychiatry, 7, 273–86.Google Scholar
Knights, A., Okasha, M. S., Salih, M. A. & Hirsch, S. R. (1979) Depressive and extrapyramidal symptoms and clinical effects: A trial of fluphenazine versus flupenthixol in maintenance of schizophrenic outpatients. British Journal of Psychiatry, 135, 515–23.CrossRefGoogle Scholar
Kuhn, R. (1958) The treatment of depressive states with G22355 (imipramine hydrochloride). American Journal of Psychiatry, 115, 459–64.Google Scholar
Kurland, A. A., Hanlon, T. E. & Ota, K. Y. (1971) Combinations of psychotherapeutic drugs in the treatment of the acutely disturbed psychiatric patient. In Advances in Neuropsychopharmacology. Amsterdam: North Holland. p 419–24.Google Scholar
Leff, J. P. & Wing, J. K. (1971) Trial of maintenance therapy in schizophrenia. British Medical Journal, iii, 559—604.Google Scholar
MacKinnon, B. L. (1977) Postpsychotic depression and the need for personal significance. American Journal of Psychiatry, 134, 427–9.Google ScholarPubMed
Markowe, M., Steinert, J. & Heyworth-Davies, F. (1967) Insulin and chlorpromazine in schizophrenia: A ten year comparative study. British Journal of Psychiatry, 113, 1101–6.CrossRefGoogle Scholar
Mayer-Gross, W. (1920) Uber die stellungsnahme auf abgelaufenen akuten psychose. Zeitschrift fur die gsamte Neurologic und Psychiatrie, 60, 160—212.CrossRefGoogle Scholar
McGlashan, T. H. & Carpenter, W. T. (1976a) An investigation of the postpsychotic depressive syndrome. American Journal of Psychiatry, 133, 14—19.Google ScholarPubMed
McGlashan, T. H. & Carpenter, W. T. (1976b) Postpsychotic depression in schizophrenia. Archives of General Psychiatry, 33, 231–9.CrossRefGoogle ScholarPubMed
Mellor, C. S. (1970) First rank symptoms of schizophrenia. British Journal of Psychiatry, 117, 15—23.CrossRefGoogle ScholarPubMed
Michaux, M. H., Kurland, A. A. & Agallianos, D. D. (1966) Chlorpromazine-chlordiazepoxide and chlorpromazine-imipramine treatment of the newly hospitalized, acutely ill psychiatric patient. Current Therapeutics and Research, 8, 117–52.Google Scholar
Overall, J. E. and Gorham, D. R. (1962) The brief psychiatric rating scale. Psychological Reports, 10, 799—812.CrossRefGoogle Scholar
Paykel, E. S., Prusoff, B. A. & Uhlenhuth, E. H. (1971) Scaling of life events. Archives of General Psychiatry, 25, 340–7.CrossRefGoogle ScholarPubMed
Piskin, V. (1972) Concept identification and psychophysiological parameters in depressed schizophrenics as functions of imipramine and nialamide. Journal of Clinical Psychology, 28, 335–9.Google Scholar
Prusoff, B. A., Williams, D. H., Weissman, M. M. & Astrachan, B. M. (1979) Treatment of secondary depression in schizophrenia. Archives of General Psychiatry, 36, 569–75.CrossRefGoogle ScholarPubMed
Rada, R. T. & Donlon, P. T. (1975) Depression and the acute schizophrenic process. Psychosomatics, 16, 116–19.CrossRefGoogle ScholarPubMed
Rifkin, A., Quitkin, F. & Klein, D. F. (1975) Akinesia, a poorly recognized drug-induced extrapyramidal behavioural disorder. Archives of General Psychiatry, 32, 672–4.Google Scholar
Rifkin, A. (1980) The risks of long-term neuroleptic treatment of schizophrenia: Especially depression and akinesia. Acta Psychiatrica Scandinavica, Supplement. In Press.Google Scholar
Roth, S. (1970) The seemingly ubiquitous depression following acute schizophrenic episodes, a neglected area of clinical discussion. American Journal of Psychiatry, 127, 91–8.Google Scholar
Semrad, E. V. (1966) Long term therapy of schizophrenia. In Psychoneuroses and Schizophrenia (ed. Usdin, E. L.). Philadelphia: J. B. Lippincott. p 155.Google Scholar
Simpson, G. M., Amuse, D., Blair, J. P. & Farkas, T. (1964) Phenothiazine produced extrapyramidal system disturbance. Archives of General Psychiatry, 10, 199—208.CrossRefGoogle Scholar
Siris, S. G., van Kammen, D. P. & Docherty, J. P. (1978) Use of antidepressant drugs in schizophrenia. Archives of General Psychiatry, 35, 1368–77.CrossRefGoogle ScholarPubMed
Steinberg, H. R., Green, R. & Durell, J. (1967) Depression occurring during the course of recovery from schizophrenic symptoms. American Journal of Psychiatry, 124, 699—702.CrossRefGoogle ScholarPubMed
van Putten, T. & May, P. R. A. (1978) Akinetic depression in schizophrenia. Archives of General Psychiatry, 35, 1101–7.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.